PTPRC and metabolic dysfunction-associated steatohepatitis: To verify the source of the increased hepatic PirB in NASH, we performed flow cytometry (FACS) and found that all the PirB+ cells in the livers were CD45+ (ND: 98.7% and CDHFD: 99.5%) (Fig. 2b).